Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 320

1.

The Metabolic Syndrome and Microvascular Complications in a Murine Model of Type 2 Diabetes.

Hur J, Dauch JR, Hinder LM, Hayes JM, Backus C, Pennathur S, Kretzler M, Brosius FC 3rd, Feldman EL.

Diabetes. 2015 May 15. pii: db150133. [Epub ahead of print]

PMID:
25979075
2.

The Role of Oxidized Cholesterol in Diabetes-Induced Lysosomal Dysfunction in the Brain.

Sims-Robinson C, Bakeman A, Rosko A, Glasser R, Feldman EL.

Mol Neurobiol. 2015 May 15. [Epub ahead of print]

PMID:
25976368
3.

Clinical Trials of Therapies for Amyotrophic Lateral Sclerosis: One Size Does Not Fit All.

Goutman SA, Feldman EL.

JAMA Neurol. 2015 May 11. doi: 10.1001/jamaneurol.2014.4275. [Epub ahead of print] No abstract available.

PMID:
25961436
4.

Intensive diabetes therapy and ocular surgery in type 1 diabetes.

DCCT/EDIC Research Group, Aiello LP, Sun W, Das A, Gangaputra S, Kiss S, Klein R, Cleary PA, Lachin JM, Nathan DM.

N Engl J Med. 2015 Apr 30;372(18):1722-33. doi: 10.1056/NEJMoa1409463.

PMID:
25923552
5.

Amyotrophic lateral sclerosis: mechanisms and therapeutics in the epigenomic era.

Paez-Colasante X, Figueroa-Romero C, Sakowski SA, Goutman SA, Feldman EL.

Nat Rev Neurol. 2015 May;11(5):266-279. doi: 10.1038/nrneurol.2015.57. Epub 2015 Apr 21. Review.

PMID:
25896087
6.

Histological Bulbar Manifestations in the ALS Rat.

Kashlan ON, Kashlan BN, Oh SS, McGinley LM, Chen KS, Kupfer R, Erman A, Sakowski SA, Feldman EL.

Neurodegener Dis. 2015;15(2):121-6. doi: 10.1159/000377725. Epub 2015 Mar 24.

PMID:
25825172
7.

The spectrum of motor neuron diseases: from childhood spinal muscular atrophy to adult amyotrophic lateral sclerosis.

Sakowski SA, Feldman EL.

Neurotherapeutics. 2015 Apr;12(2):287-9. doi: 10.1007/s13311-015-0349-7. No abstract available.

PMID:
25794940
8.

Recent advances and the future of stem cell therapies in amyotrophic lateral sclerosis.

Goutman SA, Chen KS, Feldman EL.

Neurotherapeutics. 2015 Apr;12(2):428-48. doi: 10.1007/s13311-015-0339-9.

PMID:
25776222
9.

Insulin resistance as a key link for the increased risk of cognitive impairment in the metabolic syndrome.

Kim B, Feldman EL.

Exp Mol Med. 2015 Mar 13;47:e149. doi: 10.1038/emm.2015.3. Review.

10.

Circuits and circuit disorders: approaches to neuromodulation: call for papers and new initiative with the american neurological association and the annals of neurology.

Rosenberg RN, Feldman EL.

JAMA Neurol. 2015 Apr 1;72(4):385. doi: 10.1001/jamaneurol.2015.0117. No abstract available.

PMID:
25730466
11.

The dual roles of immunity in ALS: Injury overrides protection.

Murdock BJ, Bender DE, Segal BM, Feldman EL.

Neurobiol Dis. 2015 May;77:1-12. doi: 10.1016/j.nbd.2015.02.017. Epub 2015 Feb 26. Review.

PMID:
25726748
12.

The evaluation of distal symmetric polyneuropathy: utilisation and expenditures by community neurologists.

Callaghan BC, Kerber KA, Banerjee M, Feldman EL, Morgenstern LB, Longoria R, Rodgers A, Longwell P, Lisabeth LD.

J Neurol Neurosurg Psychiatry. 2015 Jan 20. pii: jnnp-2014-307575. doi: 10.1136/jnnp-2014-307575. [Epub ahead of print] No abstract available.

PMID:
25604430
13.

Autocrine production of igf-I increases stem cell-mediated neuroprotection.

Lunn JS, Sakowski SA, McGinley LM, Pacut C, Hazel TG, Johe K, Feldman EL.

Stem Cells. 2015 May;33(5):1480-9. doi: 10.1002/stem.1933.

PMID:
25532472
14.

Hyperglycemia- and neuropathy-induced changes in mitochondria within sensory nerves.

Hamid HS, Mervak CM, M√ľnch AE, Robell NJ, Hayes JM, Porzio MT, Singleton JR, Smith AG, Feldman EL, Lentz SI.

Ann Clin Transl Neurol. 2014 Oct;1(10):799-812. doi: 10.1002/acn3.119. Epub 2014 Oct 1.

15.

Therapeutic hypothermia and targeted temperature management after cardiac arrest-reply.

Little NE, Feldman EL.

JAMA Neurol. 2014 Dec;71(12):1578. doi: 10.1001/jamaneurol.2014.3128. No abstract available.

PMID:
25486211
16.

BTBR ob/ob mice as a novel diabetic neuropathy model: Neurological characterization and gene expression analyses.

O'Brien PD, Hur J, Hayes JM, Backus C, Sakowski SA, Feldman EL.

Neurobiol Dis. 2014 Oct 30;73C:348-355. doi: 10.1016/j.nbd.2014.10.015. [Epub ahead of print]

PMID:
25447227
17.

Therapy for diabetic neuropathy: an overview.

Calabek B, Callaghan B, Feldman EL.

Handb Clin Neurol. 2014;126:317-33. doi: 10.1016/B978-0-444-53480-4.00022-9.

PMID:
25410231
18.

Global metabolomic and isobaric tagging capillary liquid chromatography-tandem mass spectrometry approaches for uncovering pathway dysfunction in diabetic mouse aorta.

Filla LA, Yuan W, Feldman EL, Li S, Edwards JL.

J Proteome Res. 2014 Dec 5;13(12):6121-34. doi: 10.1021/pr501030e. Epub 2014 Nov 13.

PMID:
25368974
19.

Epigenetic changes in bone marrow progenitor cells influence the inflammatory phenotype and alter wound healing in type 2 diabetes.

Gallagher KA, Joshi A, Carson WF, Schaller M, Allen R, Mukerjee S, Kittan N, Feldman EL, Henke PK, Hogaboam C, Burant CF, Kunkel SL.

Diabetes. 2015 Apr;64(4):1420-30. doi: 10.2337/db14-0872. Epub 2014 Nov 3.

PMID:
25368099
20.

Painful diabetic neuropathy: many similarly effective therapies with widely dissimilar costs.

Callaghan BC, Feldman EL.

Ann Intern Med. 2014 Nov 4;161(9):674-5. doi: 10.7326/M14-2157. No abstract available.

PMID:
25364890
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk